你即將離開本站

並前往https://www.fiercepharma.com/pharma/astrazenecas-fasenra-hit-fda-rejection-falling-further-behind-gsks-nucala-nasal-polyps

AstraZeneca's Fasenra hit with FDA rejection, falling further ...

Last summer, GlaxoSmithKline's rival IL-5 inhibitor Nucala earned an FDA ... a group of nasal polyps patients regardless of blood count of eosinophil—a type ...

確定！ 回上一頁

查詢 「IL-5 eosinophil」的人也找了：

  1. il-5 function
    2.
  2. il-5 inflammation
    3.
  3. il 5 security
    4.
  4. il-6
    5.
  5. il-5 proinflammatory
    6.
  6. eosinophils
    7.
  7. il-5 inhibitors
    8.
  8. il-5 drugs
    9.